Cargando…

Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases

Mixed cryoglobulinemia (MC), is a HCV-related, clinically benign, lymphoproliferative disorder (LPD) that may evolve into a non Hodgkin's lymphoma (NHL). Significant associations were found between two single nucleotide polymorphisms near NOTCH4 (rs2071286) and the HLA class II (rs9461776) gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gragnani, Laura, Fognani, Elisa, De Re, Valli, Libra, Massimo, Garozzo, Adriana, Caini, Patrizio, Cerretelli, Guia, Giovannelli, Andrea, Lorini, Serena, Monti, Monica, Bagnoli, Silvia, Piaceri, Irene, Zignego, Anna Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641068/ https://www.ncbi.nlm.nih.gov/pubmed/29069725 http://dx.doi.org/10.18632/oncotarget.17655

Ejemplares similares

149 HCV AND lymphoma: Genetic and epigenetic factors
por: Zignego, AL, et al.
Publicado: (2014)

Role of Notch Receptors in Hematologic Malignancies
por: Gragnani, Laura, et al.
Publicado: (2020)

The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis
por: Lorini, Serena, et al.
Publicado: (2020)

Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia
por: Fognani, Elisa, et al.
Publicado: (2013)

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
por: De Re, Valli, et al.
Publicado: (2016)

The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy
por: Meoni, Gaia, et al.
Publicado: (2019)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
por: Zignego, Anna Linda, et al.
Publicado: (2012)

Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis
por: Gragnani, Laura, et al.
Publicado: (2021)

Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis
por: Gragnani, Laura, et al.
Publicado: (2021)

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
por: De Re, Valli, et al.
Publicado: (2014)

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
por: Urraro, Teresa, et al.
Publicado: (2015)

B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma
por: Gragnani, Laura, et al.
Publicado: (2022)

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders
por: Buonaguro, Luigi, et al.
Publicado: (2010)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
por: Stasi, Cristina, et al.
Publicado: (2014)

Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders
por: Petrizzo, Annacarmen, et al.
Publicado: (2012)

Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals
por: Öksüz, Zehra, et al.
Publicado: (2023)

The risk of HCV infection among health-care workers and its association with extrahepatic manifestations
por: Garozzo, Adriana, et al.
Publicado: (2017)

Genetic Heterogeneity of Alzheimer’s Disease: Embracing Research Partnerships
por: Nacmias, Benedetta, et al.
Publicado: (2018)

Mutational and immunogenetic landscape of HCV‐associated B‐cell lymphoproliferative disorders
por: Defrancesco, Irene, et al.
Publicado: (2021)

Molecular Signature in HCV-Positive Lymphomas
por: De Re, Valli, et al.
Publicado: (2012)

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms
por: Yang, Lujun, et al.
Publicado: (2015)

Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
por: Butzmann, Alexandra, et al.
Publicado: (2022)

Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020
por: Zanobini, Patrizio, et al.
Publicado: (2022)

Ethanol‐induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome
por: Cerretelli, Guia, et al.
Publicado: (2021)

Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation
por: Cerretelli, Guia, et al.
Publicado: (2023)

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
por: De Re, Valli, et al.
Publicado: (2019)

Direct-acting Antivirals Induce Lymphoproliferative Disease Response in HCV-infected Patients: A Prospective Case Series
por: Hosry, Jeff, et al.
Publicado: (2017)

Characterization of Two Distinct Lymphoproliferative Diseases Caused by Ectopic Expression of the Notch Ligand DLL4 on T Cells
por: Xiong, Huizhong, et al.
Publicado: (2013)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence
por: Lastrucci, Vieri, et al.
Publicado: (2019)

COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
por: Gragnani, Laura, et al.
Publicado: (2022)

Health Literacy, Socioeconomic Status and Vaccination Uptake: A Study on Influenza Vaccination in a Population-Based Sample
por: Zanobini, Patrizio, et al.
Publicado: (2022)

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases
por: De Re, Valli, et al.
Publicado: (2020)

Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)
por: Mazzaro, Cesare, et al.
Publicado: (2021)

Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders
por: Dai, B, et al.
Publicado: (2016)

Malignant Lymphoproliferative Diseases
por: Garrett, J. V.
Publicado: (1981)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Cardiovascular and Lymphoproliferative Diseases
por: Huston, Sharon M., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_9ae8qcjjpms8cj8bgeo0imun9k